Total Payments
$71,391
2024 Payments
$418.99
Companies
53
Transactions
331
Medicare Patients
26,608
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$60,122 (84.2%)
Travel$5,959 (8.3%)
Food & Beverage$5,103 (7.1%)
Education$191.73 (0.3%)
Gifts$15.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,122 | 42 | 84.2% |
| Travel and Lodging | $5,959 | 20 | 8.3% |
| Food and Beverage | $5,103 | 265 | 7.1% |
| Education | $191.73 | 3 | 0.3% |
| Gift | $15.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Purdue Pharma L.P. | $45,730 | 64 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $11,353 | 28 | $0 (2018) |
| Depomed, Inc. | $9,299 | 29 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $546.44 | 34 | $0 (2024) |
| Vertiflex, Inc. | $359.40 | 1 | $0 (2018) |
| Averitas Pharma Inc. | $322.36 | 5 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $296.04 | 4 | $0 (2018) |
| Abbott Laboratories | $293.92 | 10 | $0 (2023) |
| Medtronic, Inc. | $293.81 | 5 | $0 (2022) |
| Daiichi Sankyo Inc. | $266.50 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.99 | 15 | Collegium Pharmaceutical, Inc. ($165.16) |
| 2023 | $612.70 | 24 | Collegium Pharmaceutical, Inc. ($169.04) |
| 2022 | $791.89 | 32 | Medtronic, Inc. ($258.49) |
| 2021 | $656.20 | 34 | GRT US Holding, Inc. ($172.71) |
| 2020 | $175.95 | 4 | Saol Therapeutics Inc. ($126.55) |
| 2019 | $320.76 | 20 | Sentynl Therapeutics, Inc. ($59.37) |
| 2018 | $20,057 | 74 | Purdue Pharma L.P. ($10,061) |
| 2017 | $48,358 | 128 | Purdue Pharma L.P. ($35,669) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| 10/05/2024 | Stryker Corporation | SPINEJACK (Device) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 09/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Opioid Analgesic | ||||||
| 08/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Opioid Analgesic | ||||||
| 08/05/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/24/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $158.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Opioid Analgesic | ||||||
| 05/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Opioid Analgesic | ||||||
| 04/09/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Opioid Analgesic | ||||||
| 03/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Opioid Analgesic | ||||||
| 02/07/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: Opioid Analgesic | ||||||
| 01/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Opioid Analgesic | ||||||
| 01/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Opioid Analgesic | ||||||
| 12/20/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Opioid Analgesic | ||||||
| 12/19/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/07/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2023 | Saluda Medical Americas, Inc. | Evoke SCS (Device) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Spinal Cord Stimulation | ||||||
| 11/07/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | ConvaTec Inc. | AQUACEL AG+ EXTRA (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 11/01/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Neuromodulation | ||||||
| 09/15/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: Opioid Analgesic | ||||||
| 09/12/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 74 | 11,143 | 36,518 | $3.3M | $1.0M |
| 2022 | 66 | 6,790 | 18,003 | $2.2M | $670,044 |
| 2021 | 53 | 3,837 | 13,056 | $1.5M | $498,520 |
| 2020 | 59 | 4,838 | 9,242 | $1.3M | $393,586 |
Total Patients
26,608
Total Services
76,819
Medicare Billing
$2.6M
Procedure Codes
252
All Medicare Procedures & Services
252 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 567 | 1,076 | $549,836 | $208,107 | 37.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 765 | 2,566 | $513,200 | $153,281 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 716 | 2,281 | $492,696 | $136,916 | 27.8% |
| J0475 | Injection, baclofen, 10 mg | Office | 2023 | 38 | 605 | $246,000 | $85,489 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 586 | $146,500 | $51,859 | 35.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 82 | 104 | $152,460 | $48,075 | 31.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 78 | 167 | $100,572 | $42,536 | 42.3% |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | Office | 2023 | 32 | 4,399 | $61,057 | $27,326 | 44.8% |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | Office | 2023 | 92 | 355 | $88,750 | $22,745 | 25.6% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 36 | 45 | $65,500 | $20,020 | 30.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 75 | 110 | $68,310 | $19,487 | 28.5% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 32 | 59 | $39,307 | $16,298 | 41.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 58 | 89 | $53,295 | $16,002 | 30.0% |
| J1170 | Injection, hydromorphone, up to 4 mg | Office | 2023 | 14 | 6,141 | $26,783 | $14,944 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $30,300 | $10,619 | 35.0% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 42 | 58 | $36,540 | $9,802 | 26.8% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Office | 2023 | 17 | 19 | $32,232 | $8,771 | 27.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 743 | 2,509 | $25,090 | $7,492 | 29.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 24 | 37 | $24,889 | $7,303 | 29.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 51 | 75 | $23,503 | $7,199 | 30.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 131 | 200 | $10,100 | $7,007 | 69.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 221 | 221 | $22,542 | $6,382 | 28.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 35 | 48 | $21,840 | $6,240 | 28.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 23 | 32 | $20,382 | $5,567 | 27.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 211 | 213 | $18,957 | $5,361 | 28.3% |
About Dr. Daniel Morris, DO
Dr. Daniel Morris, DO is a Pain Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346336856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Morris, DO has received a total of $71,391 in payments from pharmaceutical and medical device companies, with $418.99 received in 2024. These payments were reported across 331 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,122).
As a Medicare-enrolled provider, Morris has provided services to 26,608 Medicare beneficiaries, totaling 76,819 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 252 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Tulsa, OK
- Active Since 10/04/2006
- Last Updated 01/27/2026
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1346336856
Products in Payments
- HYSINGLA ER (Drug) $27,581
- SYMPROIC (Drug) $18,023
- Prialt (Drug) $11,366
- Nucynta (Drug) $9,295
- Superion ISS (Device) $359.40
- QUTENZA (Drug) $322.36
- ZOHYDRO ER (Drug) $296.04
- Belbuca (Drug) $267.27
- XTAMPZA (Drug) $244.08
- Qutenza (Drug) $242.57
- Movantik (Drug) $211.35
- Senza Spinal Cord Stimulation System (Device) $195.39
- Omnilink Elite vascular stent system (Device) $158.30
- LYRICA (Drug) $153.49
- SYNCHROMEDII (Device) $150.42
- Evoke SCS (Device) $143.98
- Lioresal (baclofen) (Drug) $126.55
- INTELLIS ADAPTIVESTIM (Device) $108.07
- ADAPTIVESTIM (Device) $107.11
- Horizant (Drug) $106.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Tulsa
Dr. Traci White, M.d, M.D
Pain Medicine — Payments: $20,568
Pain Medicine $20,568
Brian Torgerson, M.d, M.D
Pain Medicine — Payments: $15,230
Pain Medicine $15,230
Dr. Lam Nguyen, Do, DO
Pain Medicine — Payments: $15,197
Pain Medicine $15,197
Dr. Jayen Patel, Md, MD
Pain Medicine — Payments: $14,399
Pain Medicine $14,399
Dr. Adam Wallace, M.d, M.D
Pain Medicine — Payments: $10,960
Pain Medicine $10,960
Kenneth Reed, Md, MD
Pain Medicine — Payments: $10,938
Pain Medicine $10,938